|
|
Cardiovascular Oral Solid Dosage
| S.No. |
Product Name |
Strengths |
Pack Style |
Current Status |
Dossier Timelines (6M Stability) |
| 1 |
Amlodipine Tablets |
5mg |
3 x 10 |
Under development |
Q2 |
| 10mg |
3 x 10 |
Under development |
Q2 |
| 20mg |
3 x 10 |
Under development |
Q2 |
| 2 |
Amlodipine + Atenolol Tablets |
5mg + 50mg |
3 x 10 |
Available |
Available |
| 3 |
Amlodipine + Losartan Tablets |
5mg + 50mg |
3 x 10 |
Under development |
Q3 |
| 4 |
Atenlol Tablets |
50mg |
3 x 10 |
Under development |
Q2 |
| 100mg |
3 x 10 |
Under development |
Q2 |
| 5 |
Atorvastatin Tablets |
10mg |
3 x 10 |
Available |
Available |
| 20mg |
3 x 10 |
Available |
Available |
| 40mg |
3 x 10 |
Available |
Available |
| 6 |
Clopidogrel Tablets |
75mg |
3 x 10 |
Available |
Available |
| 7 |
Carvedilol Tablets |
6.25mg |
3 x 10 |
Under development |
Q4 |
| 12.5mg |
3 x 10 |
Under development |
Q4 |
| 8 |
Telmisartan Tablets |
40mg |
3 x 10 |
Under development |
Q4 |
| 80mg |
3 x 10 |
Under development |
Q4 |
| 9 |
Telmisartan & Amlodipine Tablets |
40mg + 5mg |
3 x 10 |
Under development |
Q4 |
| 10 |
Telmisartan + Hydrochlorothiazide Tablets |
40mg + 12.5mg |
3 x 10 |
Under development |
Q4 |
| 8 mg + 12.5mg |
3 x 10 |
Under development |
Q4 |
|
| |
|